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Proprotein processing activity of the KexZ-like mammalian endoprotease PACE4 and its cleavage selectivity for sites with basic amino acid residues 
were determined. Using a recombinant vaccinia virus-based expression system, PACE4 was expressed in pig kidney PK( 15) cells and, like two other 
Kex2-like endoproteases furin and PC6A, shown to correctly process the precursor of von Willebrand factor (pro-vWF). Furthermore, character- 
istics of the cleavage site selectivity of PACE4 were compared to those of furin and PC6A using the vWF cleavage site mutants vWFR-lG, 
vWFK-ZA, and vWFR-4A as substrates. Cleavage site selectivity of PACE4 and PC6A appeared to be similar but they differed from that of furin. 
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1. INTRODUCTION 
Recently, a novel family of eukaryotic endoprote- 
olytic processing enzymes has been identified whose 
members appear capable to release biologically active 
polypeptides from inactive precursor proteins by cleav- 
ing the latter at sites with paired basic amino acid resi- 
dues (for review see [l-3]). Such precursors include 
those for a variety of polypeptide hormones, neuropep- 
tides, growth factors, growth factor receptors, plasma 
proteins, and viral glycoproteins [4]. The first known 
enzyme of this novel family is the Kex2 protease of yeast 
Saccharomyces cerevisiae, a Ca*‘-dependent serine pro- 
tease with a subtilisin-like catalytic domain and in- 
volved in processing of pro-a-mating factor and pro- 
killer toxin [5,6]. The mammalian prototype is furin [7], 
a ubiquitously expressed [8,9] KexZlike [lo] enzyme 
with demonstrated cleavage specificity for sequences 
with multiple basic amino acid residues [l l-141. Other 
mammalian enzymes are PClIpC3 and PC2 [15-171, 
expression of which has sofar been found only in neuro- 
endocrine cells, PC4 [ 18,191, which is expressed in sper- 
matogenic ells, the ubiquitously expressed PACE4 [20], 
and, finally, PC6 [21,22], which is also known as PC5 
[23]. PC6 occurs in two isoforms; PC6A [21], which has 
been found in a variety of tissues and cell lines, and 
PC6B [22], which has a much larger cysteine-rich region 
than PC6A and has been found mainly in intestine. For 
most of the mammalian KexZlike endoproteases, the 
cleavage specificity and the requirement of basic amino 
acid residues immediately amino-terminally to the 
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cleavage site have been established in co-expression ex- 
periments. However, not yet for PACE4. 
The structural organization of the mammalian proc- 
essing enzymes of this novel family appears to be highly 
similar, although they also contain unique features. One 
common feature of all enzymes is that they seem to be 
synthesized initially as zymogens, all with multiple basic 
residues at the presumed maturation cleavage site. Only 
the mature enzyme is assumed to be capable of process- 
ing substrates, therefore, removal of the pro-domain 
seems to be essential for acquiring substrate cleavage 
activity [24,25]. For human furin, it has been demon- 
strated that removal of its pro-domain takes place at the 
predicted cleavage site (K-R-R-T-K-Rlo7 1) and occurs 
via an intramolecular autoproteolytic process [24,25]. 
Another common feature of these enzymes is that their 
subtilisin-like catalytic domains are highly similar [26]. 
However, positional requirements with respect to basic 
amino acid residues next to the cleavage site in a sub- 
strate seem to vary. The neuroendocrine-specific en- 
doproteases PCl/PC3 and PC2 preferentially cleave 
carboxy-terminally of paired basic residues, Lys-Arg or 
Arg-Arg [27]. In contrast, the preferred site for cleavage 
by furin seems to be the consensus equence Arg-X-A& 
Lys-Arg [28], although furin is also capable to process 
efficiently cleavage site mutants of the precursor of von 
Willebrand factor (pro-vWF) with basic residues at the 
Pl and P2 or at the Pl and P4 positions only [25]. From 
recent site-directed mutagenesis studies of furin, further 
insight was obtained in structural features that seem to 
control selectivity of the enzyme for the basic residues 
in a cleavage site [25]. It was demonstrated that partic- 
ular negatively charged residues in or near the Sl-S4 
Published by Elsevier Science Publishers B. K 65 
Volume 336, number 1 FEBS LETTERS December 1993 
subsites of the substrate-binding region of furin are crit- 
ical. Other negative charges were predicted to contrib- 
ute to substrate binding in the S3, S5 and S6 subsites 
([25] and Siezen et al., in preparation). 
Here, we report results of studies in which the propro- 
tein processing activity of PACE4 is established and 
requirements with respect to the positioning of basic 
residues next to the cleavage site in a substrate are de- 
fined. As substrates, wild-type von Willebrand factor 
(vWF) and three cleavage site mutants of vWF were 
used; the latter included Pl mutant vWFR-lG, P2 mu- 
tant vWFK-2A, and P4 mutant vWFR-4A. Our studies 
indicate that cleavage site selectivity of PACE4 resem- 
bles that of PC6A and differs from that of furin. Cleav- 
age by PACE4 and PC6A is apparently restricted to a 
limited variation in the positioning of the basic residues 
next to the substrate cleavage site. This in contrast to 
furin which appears to be a more multi-purpose proc- 
essing enzyme. 
2. MATERIALS AND METHODS 
2.1. cDNAs and molecular cloning 
A mouse Nor1 cDNA fragment containing all coding sequences of 
PC6A [21] was cloned into pGEMl3Zf(+) (Promega) allowing expres- 
sion under control of the T7 promoter. The resulting clone was named 
pGEMPC6A. pGEMPC6A DNA was then digested with restriction 
endonucleases AccI and Hind111 to remove all coding sequences of 
PC6A 3’ of the signal peptide sequence. Human PACE4 sequences 
were derived from a PACE4 cDNA cloned into the Not1 site of 
pBluescript II KS(+) (Stratagene); this cDNA clone contained all 
PACE4 coding sequences except for 43 nucleotides at the 5’ end [20]. 
DNA of this PACE4 clone was digested with restriction endonuclease 
Hind111 and partially digested with AccI to obtain a 3.2 kbp PACE4 
cDNA fragment, which contained all PACE4 coding sequences except 
those encoding the signal peptide. The 3.2 kbp AccI-Hind111 PACE4 
cDNA was ligated to the AccI-Hind111 pGEMPC6A DNA fragment 
and the resulting construct was named pGEMPRE,,,PACE4. 
pGEMPRE,,PACEA DNA encodes a chimeric protein composed 
of the PC6A signal peptide linked to pro-PACE4 as outlined in Fig. 
1. pGEMFUR contains the coding sequences for human furin. 
2.2. Infection and lipofection of PK(15) cells 
Pig kidney PK( 15) cells were propagated in DMEM supplemented 
with fetal calf serum (10% v/v), glutamine (2 mM) and antibiotics 
(penicillin (100 U/ml) and streptomycin (100 &ml)). Cells were in- 
fected with recombinant vaccinia virus V.V.:TII at an m.o.i. of 5 in 
medium containing bovine senmr albumin (20 pug/ml). Recombinant 
vaccinia virus V.V.:T7 produces T7 RNA polymerase [29]. After infec- 
tion for 1 h, medium was removed and cells were lipofected for 16 
18 h with 4 pg DNA using DOTAP transfection-reagent (Boehringer 
Mannheim Biochemical), according to the suppliers instructions. Re- 
combinant DNA constructs, which express human furin, wild type 
pro-vWF (cleavage site R-S-K-R763 1) or pro-vWF cleavage site mu- 
tants vWFR-1G (Pl mutant, cleavage site R-S-K-G763 l), vWFK-2A 
(P2 mutant, cleavage site R-S-A-R7631) or vWFR-4A (P4 mutant, 
cleavage site A-S-K-R763 1) under control of the T7 promoter, have 
been described elsewhere [25]. 
2.3. Radiolabelling of cells and analysis of biosynthesis of proprotein 
processing enzymes (111s Y WF substrates 
Biosynthesis of proprotein processing enzymes (furin, PC6A and 
PACE4) and pro-vWF substrates (wild-type pro-vWF and pro-vWF 
cleavage site mutants) were studied 16-18 h after lipofection. Prior to 
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radiolabelling of PK(15) cells, medium was removed and cells were 
incubated for 1 h in RPM1 medium that lacked methionine. Subse- 
quently, cells were labelled for 30 min in the presence of [35S]methion- 
ine (100 @iiml, spec. act. > 800 Ci/mmol), followed by a chase of 4 
h with unlabelled methionine (final concentration 1 mM). After cen- 
trifugation for 5 min at 3,000 rpm, the medium samples were concen- 
trated by TCA-precipitation in the presence of bovine serum albumin 
(50 &ml). All samples were analyzed under reducing conditions on 
a 5% SDS-polyacrylamide gel. 
3. RESULTS AND DISCUSSION 
To establish that PACE4 is indeed a genuine member 
of the Kex2 family of endoproteases, proprotein proc- 
essing studies were performed, first with wild-type pro- 
vWF as a substrate. Since the structures of PACE4 and 
PC6A were reported to be strikingly similar [21], mouse 
PC6A was included in the study to allow comparison of 
the biological activities of the two proteins. Furin, the 
mammalian prototype of this novel family of processing 
enzymes, was also included. To efficiently express the 
processing enzymes and the pro-vWF substrate, we de- 
cided to clone the corresponding cDNAs into 
pGEMl3Zf(+), allowing expression under control of 
the T7 promoter, and to use pig kidney PK( 15) cells that 
were infected with recombinant vaccinia virus V.V.:T7 
as host cells; upon V.V.:T’I infection, the PK(15) cells 
were previously shown to produce relatively large quan- 
tities of T7 RNA polymerase [25]. It should be noted 
that in this expression system, endogenous protein syn- 
thesis is highly suppressed allowing direct detection of 
secreted proteins without additional purification steps 
and thus monitoring the biosynthesis of PACE4 and 
PC6A. This was important since specific anti-PACE4 
and anti-PC6A antibodies to detect these proteins in 
immunoprecipitation or Western blot analysis were not 
pm pro catalytic middle CRR 
PACE4 
PCBA 
t 
PRE ,A-PACE4 
Fig. 1. Construction of chimeric PRE,,-PACE4 which encodes a 
precursor protein that consists of the PC6A signal peptide and pro- 
PACE4. The predicted mature product encoded by PRE,,-PACE4 
DNA is assumed to be identical to wild-type PACE4 Domain swap- 
ping was performed just upstream of identical regions of the PC6A 
and PACE4 proteins, as is indicated by a connecting line. Predicted 
signal cleavage sites are indicated with arrows. The resulting chimeric 
PRE ,,-PACE4 protein is shown in the lower part of the figure. 
Volume 336, number 1 FEBS LETTERS December 1993 
kDa 
97 - 
f38- 
Fig. 2. Biosynthesis of furin, PACE4 and PC6A. After infection of 
PK(lJ) cells with V.V.:T;I virus, cells were lipofsted with 4 ,ug of 
pGEMFUR, pGEMPRE,,PACEA or pGEMPC6A DNA, as indi- 
cated. Analysis of the newly synthesized proteins was performed as 
described in Materials and Methods. In the first lane, proteins pro- 
duced by cells that were not lipofeeted (nl) are shown. Relative posi- 
tions of furin, PACE4 and PC6A are indicated with arrows. 
available. As far as PC6A was concerned, relatively 
high levels of PCBA were obtained in PK( 15) cells (data 
not shown). For PACE4, however, the available cDNA 
appeared to be incomplete and to lack S-end coding 
sequences. Probably because of the fact that the missing 
5’ region was very GC-rich, it appeared ifficult to clone 
the missing sequences by using the polymerase chain 
reaction (PCR). As an alternative approach, we con- 
structed chimeric DNA PRE,,-PACE4, which con- 
sisted of the S-end sequences of PC6A, including the 
signal peptide cleavage site, and the PACE4 sequences 
encoding pro-PACE4 (Fig. 1). The fusion site of the 
PC6A and PACE4 sequences was selected close to the 
sites where the signal peptides were assumed to be 
cleaved off. Wi~n these regions, the deduced amino 
acid sequences of PACE4 and FC6A appeared to be 
identical over a stretch of eight amino acids and highly 
similar throughout the entire pro-region. This facili- 
tated the planned exchange and reduced the possibility 
of disturbing secondary structures. In fact, of all dibasic 
processing enzymes presently known, PC6A appeared 
to structurally resemble PACE4 the most. It should be 
noted that the predicted signal peptide of PACE4 is 
larger than that of PC6A [20-221. Since the site for 
cleaving off the PC6A signal peptide was preserved in 
PREPc,,- PACE4, it was expected that this would occur 
normally. The predicted mature product encoded by 
PRErcGA-PACE4 DNA was assumed to be identical to 
wild-type PACE4. Finally, it appeared that the se- 
quences around the putative initiation codon for PC6A 
were in better agreement with Kozak’s rules [30] than 
those around the predicted start codon for PACE4. In 
light of this all, similar high expression levels of PACE4 
encoded by PREpceA-PACE4 DNA were expected as 
observed in pilot experiments for PC6A. In Fig. 2 the 
secreted levels of human furin, human PACE4, and 
mouse PC6A found in the medium of PK(15) cells are 
shown. The molecular weight of the secreted form of 
human furin was estimated to be about 85 kDa, as has 
been reported before [31,32]; it presumably corresponds 
to a processed form of fur-in lacking the carboxy-termi- 
nal transmembrane domain. The electrophoretic mobil- 
ities of secreted PACE4 and PC6A appeared to be sim- 
ilar, with that of PC6A slightly higher. Their observed 
molecular weights were estimated to be about 115 kDa 
which is somewhat higher than their calculated molecu- 
lar weights and this might be due to glycosylation [20- 
221. The appearance of rather broad bands in SDS- 
PAGE might also reflect this or might point towards the 
presence of double bands as observed with the jllroso- 
phila furins [33]. The results of the expression experi- 
ments clearly established that PACE4 and PC6A were 
synthesized at relatively high levels in PK(15) cells 
under the selected expression conditions. This opened 
the way to assay the predicted proprotein processing 
activity of PACE4 
To establish that PACE4 indeed possesses proprotein 
processing activity with specificity for cleavage sites 
with paired basic amino acids, we studied its ability to 
process wild-type pro-vWF in similar co-expression ex- 
periments as performed before for furin [ 11,14,25]. As 
can be seen in Fig. 3 (row l), transfection into PK(15) 
cells of pGEMvWF DNA, which encodes wild-type 
pro-vWF, resulted in the production of pro-vWF and 
a minute amount of mature vWF. The production of 
some mature vWF is assumed to be the result of proc- 
essing by endogenous furin or a furin-like processing 
enzyme. Due to the viral infection, however, this en- 
dogenous activity appeared to be suppressed almost 
completely, thus making the assay rather sensitive with 
c\ 
vWF 
(R-S-K-R) 
vWFA-I G 
(R-S-K-G) 
vWFK-2A 
(R-S-A-R) 
VWFR-QA 
(A-S-K-R) 
- pro-vWF 
_ VWF 
- - pro-vWF 
h+: -vWF 
- pro-vWF 
- VWF 
Fig. 3. Analysis of endoproteolytic processing of pro-vWF, pro- 
vWFR-lG, pro-vWFK-2A and pro-vWFR-4A. PK( 15) cells were first 
infected with recombinant vaccinia virus V.V.:T”I and subsequently 
lipofected with 2 pg of pGEMvWF DNA (first row, except the first 
lane), pGEMvWFR-1G DNA (second row), pGEMvWFK-2A DNA 
(third row) or pGEMvWFR_IA DNA (fourth row) in combination 
with 2 /~g of either pGEM vector DNA (indicated with -), 
pGEMFUR DNA, pGEMPRhPACE4 or pGEMPC6A DNA, as 
is indicated above the lanes. In the first lane of the upper row, VV.:T7- 
encoded proteins secreted from cells that were not lipofected (nl) are 
shown. 
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respect to detecting exogenous processing activity. 
Cotransfection of pGEMvWF and pGEMFUR DNA 
resulted in the production of only mature vWF. Appar- 
ently, pro-vWF is processed into mature vWF to com- 
pletion by exogenous furin. Almost complete processing 
of pro-vWF was observed when PC6A was coexpressed. 
In case of PACE4, enhanced processing of pro-vWF 
was observed, however, not all pro-vWF could be con- 
verted into mature vWF. The results of these co-expres- 
sion studies indicate that PACE4 can process pro-vWF 
into mature vWF in a similar way as the enzymes furin 
and PC6A do. This establishes the membership of 
PACE4 of the Kex2 family of proprotein processing 
enzymes. 
The fact that PACE4 seemed to be less efficient in 
processing pro-vWF as compared to human furin and 
mouse PC6A points towards potential differences be- 
tween these enzymes, possibly differences in cleavage 
site specificity. To address this issue, we have studied 
the capabilities of PACE4 and PC6A to process cleav- 
age site mutants of pro-vWF in which basic residues 
next to the processing site had been submitted. Experi- 
ments with Pl mutant cWFR-1G in which the arginine 
residue (Arg763 in the Pl position) had been substituted 
by a glycine revealed that none of the three processing 
enzymes, furin, PACE4 or PC6A, could process its pre- 
cursor, pro-vWFR-1G (Fig. 3, row 2). From observa- 
tions of earlier studies of furin [25,34], it had become 
clear already that the Arg763 residue in the Pl position 
is very critical. The Sl binding pocket is predicted to be 
a large, elongated pocket with residue D 199 dominantly 
involved in electrostatic interaction with the Pl basic 
residue (Arg763). On the other hand, substitution of the 
arginine into glycine might also be very unfavourable 
since glycine is much smaller than arginine and in fact 
has no side chain that could interact with either a nega- 
tively charged residue or a hydrophobic residue of the 
Sl binding pocket. Experiments with P2 mutant 
vWFK-2A in which Lys7‘j2 was replaced by an alanine 
indicated that both PACE4 and PC6A were capable to 
process to some extent the corresponding precursor 
pro-vWFK-2A but apparently not as completely as 
achieved with furin. PACE4 and PC6A were found to 
process only minute amounts, if any at all, of the precur- 
sor of P4 mutant vWFR4A in which Arg760 was re- 
placed by an alanine; in contrast, human furin could 
process pro-vWFR-4A, to a large extent. With respect 
to their ability to process the three cleavage site mutants 
of the von Willebrand factor, the proprotein processing 
enzymes PACE4 and PC6A seem to resemble ach other 
but to differ from the widely expressed enzyme furin. 
Processing characteristics of PC6A have been de- 
scribed before [21]. They were obtained in co-expression 
studies using rat pituitary GH,C, cells and native or 
mutant prorenin of mouse as substrates. In these stud- 
ies, only very limited processing was observed of native 
mouse Ren-2 prorenin which possesses the following 
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cleavage site E-W-D-V-F-T-K-R63 1 -S-S-L-T. Intro- 
duction of an arginine residue at the P4 position (re- 
placement of Phe’jO by Arg) resulted in enhanced cleav- 
age of this prorenin mutant. Prorenin mutants with 
arginine residues in the Pl (Arg63) and P4 (Arg@‘), or 
only in the Pl (Arg63) position were not processed. In 
general, the results of our studies are in good agreement 
with these observations. The only apparent discrepancy 
seems to be the processing of the substrate with basic 
residues at the Pl (residue 63) and P4 (residue 60) posi- 
tion. It is possible that the assay system that we used in 
our studies is more sensitive than the one used by Na- 
kagawa et al. [21]. Furthermore, the fact that different 
cell types, substrates, and expression systems were used 
might also explain the observed difference. 
Comparison of nine negatively charged and presuma- 
bly critical amino acid residues in the Sl-S6 subsites of 
the substrate binding regions of human furin, human 
PACE4, and mouse PC6A revealed no differences be- 
tween those of PACE4 and PC6A. Compared to furin, 
however, two residues appeared to be different. In light 
of the fact they were found in the S3 and S5 binding 
pockets, it is difficult to imagine that they constitute an 
important factor for the observed differences in cleav- 
age site selectivity between PACE4 and PC6A on the 
one hand and furin on the other hand. One should also 
bear in mind that proprotein conversion is also deter- 
mined by other structural features of the substrate and, 
furthermore, by the intracellular microenvironment 
where the actual processing step takes place. 
In conclusion, our studies establish that PACE4 is a 
member of the Kex2 family of proprotein processing 
enzymes and that, as far as positional requirements for 
basic amino acid residues next to the cleavage site in the 
substrate are concerned, there seem to be more con- 
straints for proper functioning of PACE4 and PC6A as 
compared to furin. Furin, more or less, seems to be a 
general or multi-purpose processing enzyme. The differ- 
ences in cleavage site requirements observed here be- 
tween PACEA and PC6A on one side and furin on the 
other side seem to further support the increasingly more 
clear functional diversity among the members of this 
novel family of mammalian subtilisin-like proprotein 
processing enzymes. 
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